Skip navigation
Full metadata record
DC FieldValueLanguage
dc.contributor.authorEconomides, Nicholas-
dc.contributor.authorSchwartz, Robert A.-
dc.date.accessioned2008-05-25T06:42:52Z-
dc.date.available2008-05-25T06:42:52Z-
dc.date.issued1995-11-
dc.identifier.urihttp://hdl.handle.net/2451/26257-
dc.description.abstractThis paper summarizes the responses to a questionnaire sent to equity traders through TraderForum of the Institutional Investor. The respondents manage in total a very significant percentage of equity assets under management in the United States. The focus of the questions was the extent of the demand for immediate execution of orders. We found that the majority of traders are willing to trade patiently if this reduces execution costs. Many traders indicate that they frequently delay trades to obtain better prices. Most respondents indicate that they are typically given more than a day to implement a large order, that they typically break up more than 20% of their large orders for execution over time, and that they regularly take more than a day for a large order that has been broken into lots to be executed completely. There is a generally positive view of alternative electronic trading systems, such as Instinet and Investment Technology Group’s POSIT. The key motives for trading on these systems are reduced market impact, lower spreads, better liquidity, and anonymity. The respondents indicate that the key changes that would make alternative electronic systems more attractive are an increase in execution rates and more convenient times of trading. The responses to the survey also show that alternative electronic systems would be used more if the traders did not have soft dollar arrangements.en
dc.language.isoen_USen
dc.relation.ispartofseriesEC-95-08en
dc.titleEquity Trading Practices and Market Structure: Assessing Asset Managers' Demand for Immediacyen
dc.typeWorking Paperen
Appears in Collections:Economics Working Papers

Files in This Item:
File Description SizeFormat 
95-08.pdf1.61 MBAdobe PDFView/Open


Items in FDA are protected by copyright, with all rights reserved, unless otherwise indicated.